Haemophilus influenzae molecular isolates.British Journal of ophthalmology 86(3):276-277.
3- Berenson CS, Murphy TF, Wrona CT, Sethi S. Outer membrane protein p6 ofnontypeable Haemophilus influenzae is a potent andselective inducer of human macrophageproinflammatory cytokines. Infect Immun. 2005;73: 2728-2735.
4- Breukels MA, Spanjaard L, Sanders LA, Rijkers GT. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.Clin Infect Dis. 2001; 32:1700.
5- Cotter D, Manson K, Howell AP, Fink DL, Green BA. Immunization with Haemophilus influenzae Hapadhesin protects against nasopharyngeal colonizationin experimental mice. J Infect Dis. 2002; 186:1115-1121.
6- Cotter SE, Yeo HJ, JuehneT, St Geme I. Architecture and adhesive activity of the Haemophilus influenza Hsfadhesin. وJBacteriol. 2005; 187:4656-4664.
7- Doran L. Fink 1, 2,3Amy Z. Buscher1, 2, 3, Bruce Green4, phillip Fernsten4,JosephW. St. Gemel1, 2, 3, Article the first public shed online (March2003):4MAR 2003 DOI:10. 1046/j. 1462-5822.2003. 00266. x:The Haemophilus influenza Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding in the C-terminal end of the passenger domain. Cellular Microbiology Volume 5,Issue 3,pages175-186.
8- Duim B,1993. Genetic analysis of the diversity in outer membrane protein P2 of non-encapsulated Haemophilus influenza.Microbial pathogenesis,1993;14:451-462. Available from: http://books.google.com/books?id=ZXFcBAAAQBAJ&pg=PA100&lpg=PA100&dq=genetic+analysis+of+the+diversity+in+outer+membrane+protein[1392/4]
9- Dworkin,M. S. ,park,L. ,Borchardt,S. M. ,2007. The changing epidemiology of invasive Haemophilus disease ,especially in persons65 years old. clin. Infect. Dis. 44,810-816.5,Issue 3,pages175-186.
10- Dworkin,M. S. ,park,L. ,Borchardt,S. M. ,2007. The changing epidemiology of invasive Haemophilus disease ,especially in persons65 years old. clin. Infect. Dis. 44,810-816.
11- Esmaily.F,A. M. ,Tavangar. AR,Hadi. A(2011). Comparison of bacterial biomass and PRP production between different isolates of Haemophilus influenza type b (Hib) under different culture conditions.Razi vaccine &Serum Research Institute66(1):7.
12- Forbes KJ and el,1992,Variation in length and sequence of porin (ompP2) alleles of non-capsulate Haemophilus influenzae. 1992,Mol Microbiol. 2107-12. Available from: http://www.ncbi. nlm. nih. gov/pubmed/1328812[1392/5]
13- Forsgren A, Riesbeck K, Janson H. Protein D of Haemophilus influenzae: a protectivenontypeable Haemophilus influenzae antigen and acarrier for pneumococcal conjugate vaccines. . Clin Infect Dis. 2008;46: 726-731.
14- FoxwellAR,KydJM,CrippsAW. Nontypeable Haemophilusinfluenzae: pathogenesis and prevention. Microbiol Mol Biol Rev. 1998;62:294-308.
15- Goldblatt D, VazAR, Miller E. Antibody avidity as a surrogatemarker of successful priming by Haemophilus influenzatype b conjugate vaccines following infant immunization.J Infect Dis. 1998;177:1112.
16- Haase EM, Morse GD, Murphy TF.Mapping of Bactericidal Epitopes on the P2 Porin Protein of Nontypeable Haemophilus influenzae.Infect Immun. 1994;62(9):3712-22. . Available from: http://www.ncbi. nlm. nih. gov/pmc/articles/PMC303022[1392/4].
17- Hiltke, T. J. , S. Sethi, and T. F. Murphy, Sequence stability of the gene encoding outer membrane protein P2 of nontypeable Haemophilus influenzae in the human respiratory tract. J Infect Dis, 2002. 185(5): p. 627-31
18- Hiltke Tj and el,2003, Horizontal transfer of the gene encoding outer membrane protein P2 of nontypeable Haemophilus influenzae, in a patient with chronic obstructive pulmonary disease. 2003,PUBMED,1;188(1):114-7. http://www.ncbi. nlm. nih. gov/pubmed/12825179,[1392/4]
19- Hiltke Tj el,2002. Sequence stability of the gene encoding outer membrane protein P2 of nontypeable Haemophilus influenzae in the human respiratory tract.J Infect Dis. 2002 Mar 1;185(5):627-3,Available from: http://www. ncbi. nlm. nih. gov/pubmed/11865419,[1393/3]
20- Inoshima,Y. ,A. Morooka,et al. (2000)Simple preparation of parapoxvius genome DNA for endonuclease analysis. Microbiology and Immunology 44(1):69-72.
21- Ishida Y،Abe Y،Yanaia M،Kobayashi H،Harabuch Y. Identification of human T-cell epitopes and highlyimmunogenic analog peptides on the non-typeableHaemophilus-influenzae P6 outer membrane protein.Clin Immunol. 2006;121:90-99.
22- Janson,H. ,M. Ruan,et al. (1993). Limited diversity of the Protein -D gene (HPI)amoung encapsulated and noncapsulated Haemophilus-Influenzae strains. Infection and Immunity 61(11):4546-4552.
23- Kennedy S. ,Oswald N. ,PCR Troubleshooting and optimization :The Essential Guide ,1stedn. 2011. Available from: http://www.amazon. com/PCR-Troubleshooting -Optimization-Essential-Guide/dp/1904455727.
24- Kubiet, M. and Ramphal, R. (1995) Adhesion of nontypeable Haemophilusinfluenzae from blood and sputum to human tracheobronchial mucins andlactoferrin. Infect. Immun. 63,899-902.
25- Kyd JM, Cripps AM, Novotny LA, Bakaletz LO. Efficacy of the 26-Kilodalton Outer Membrane Protein and Two P5Fimbrin-Derived Immunogens To Induce Clearance of NontypeableHaemophilus influenzae from the Rat Middle Ear and Lungs asWell as from the Chinchilla Middle Ear and Nasopharynx. Infect Immun. 2003;71(8):4691-4699.
26- Ladhani,S. ,Slack,M. P. ,White,j. ,Ramsay,Fall in Haemophilus influenezae serotype b(Hib) disease following implementation of a boostercampain. Arch. Dis. child.93,665669.
27- Larson,T. J. ,Ehrmann,et al. (1983). Periplasmic Glycerophosphodiester phosphodiesterase of Escherichia -Coli,A New Enzyme of the Glp Regulon. journal of Biological Chemistry 258(9):5428-5432.
28- Lindberg A. Glycoprotein conjugate vaccines. Vaccine.1999;17:s28-s36. 44-Ada G, Isaacs D. Carbohydrate- protein vaccines.Clin Microbiol Infect. 2003; 9:79-85.
29- Orkin ,S. (1990). Molecular cloning a laboratorymanual,2nedition,sambrook,j ,Fritsch, EF,Maniatis,T. Nature 343(6259)604-605.
30- Mandell GL, Bennett JE, Dollin R. Principles and practice of infectious disease.7th edition, Churchill Livingstone, Elsevier;2010,1, P. 1079-1171.
31- Mandell GL, Bennett JE, Dollin R. Principles and practice of infectious disease.7th edition, Churchill Livingstone, Elsevier;2010,vol. 2, P. 2911-2921.
32- Manson ,RS,et al,Purfication and comparison of outer membrane protein P2 from Haemophilus influenza Type b isolates. Clinical Investigation.1983;72(2):677-684. doi:10. 1172/JCI111017. Available from: http://www.jci.org/articles/view/111017[1393/3]
33- Martin, D. , et al. , Mapping of B-cell epitopes on the outer membrane P2 porin protein of Haemophilus influenzae by using recombinant proteins and synthetic peptides.Infect Immun, 1991. 59(4): p. 1457-64
34- Metcalf BJ.Production of thelapidated formof the Peptidoglycan-associatedlipoproteinsofgram-negativebacteria. Available from: http://www. faqs. org/patents/app/20090060952).
35- Meyers,J. A. ,D. Sanchez,et al. (1976). Simple agarose-gel electrophoretic method for identification and characterization of plasmid deoxyribonucleic-acid.Journal of Bacteriology 127(3):1529-1537.
36- Moreno, E. 1999.Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. Infect. Immun. 43: 779
37- Murley YM, Edlind TD, Plett PA, LiPuma JJ.Cloning of thehaemocin locus of Haemophilus influenzaetype b and assessment of the role of haemocinin virulence.Microbiology.1998;144: 2531-2533.
38- Murphy TF, Bartos LA, Campagnari AA, Nelson MB, Apicella MA.Antigenic -Characterization of the P6 Protein of Nontypable Haemophilus influenzae. Infect Immun. 1986;54(3):774-779.
39- Murphy TF, Pastor P, Medley F, Osterholm MT, GranoffDM.Decreased Haemophilus colonization in children vaccinatedwith Haemophilus influenzae type b conjugate vaccine.J Pediatr.1993;122:517.
40- Murphy TF.Respiratory infections caused by non-typeable Haemophilusinfluenzae. Curr Opin Infect Dis 2003;16:129-34.
41- Musser, J. M. , Barenkamp, S. J. , Granoff, D. M. , and Selander, R. K. (1986)Genetic relationships of serologically nontypeable and serotype b strains ofHaemophilus influenzae. Infect. Immun. 52,183-191.
42- Nakamura M, Asaka T, Kirita A, Miyazaki H, Senda Y, Fujita SI, Fukushima R. Occurrence of the Fimbria GenehifA in Clinical Isolates of nonencapsulated-Haemophilus influenzae. Microbiol Immunol. 2006; 50:327-329.
43- Niazi A. Rahman,Comparison of Virulence Determinants of DifferentStrains of Haemophilusinfluenzae. School of Biomedical Science,Curtin University of Technology, Perth WA,Australia,2009.
44- Peltola H. Worldwide Haemophilus influenzae Type b Disease at the Beginningof the 21st Century: Global Analysis of the Disease Burden25 Years after the Use of the Polysaccharide Vaccineand a Decade after the Advent of Conjugates. Clin Microbiol Rev. 2000;13(2):302-317.
45- Prasadarao,N. V. ,E. Lysenko,et al. (1999). Opacity associated protein a contributes to the binding of Haemophilus influenza to chang epithelial cells. Infection and Immunity 67(8):41534160.
46- Pickering Jerry W, Martins Thomas B,Schroder M. Carl and Hill Harry R. ,2002,Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus,Diphtheria and Haemophilus influenzatype b. Clin vaccine. Immunol,9(4): 879-876.
47- Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typableHaemophilus influenzae: a

دسته بندی : No category

دیدگاهتان را بنویسید